Human Coagulation Factor Ⅷ（Tonrol Bio-Pharmaceutical ）

人凝血因子Ⅷ（同路生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Coagulation Factor Ⅷ（Tonrol Bio-Pharmaceutical ）
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2013/08/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonrol Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTonrol Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksN/A